Skip to content

Assessment Of Karkotimoolayoga In the treatment Of Mutrashmari (Urolithiais)

Study Of Karkotimoolayoga In The Management Of Mutrashmari (Urolithiasis) - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080307
Enrollment
30
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N29- Other disorders of kidney and ureter in diseases classified elsewhere

Interventions

None listed

Sponsors

DrRushikesh Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with samanya Lakshanas of Mutrashmari as per the classics. 2.Patients presenting less than 10mm calculi. 3.Patients of age between 18-70 years of both gender. 4.Patients having calculi in renal,ureter,urinary bladder and ureteric vesicle junction.

Exclusion criteria

Exclusion criteria: Patient having Mutrashmari associated with, 1.Acute renal failure 2.Chronic renal failure 3.Pregnancy and lactating mother. 4.Staghorn Calculus. 5.Polycystic kidney disease. 6.Pyelonephritis.

Design outcomes

Primary

MeasureTime frame
1.Reduction in size of mutrashmari.Timepoint: 10 days

Secondary

MeasureTime frame
Reduction in pain in abdomen(udarashoola),Dysuria(sashoola mutrapravrutti),Haematuria(sarakta mutrapravrutti)Timepoint: 10 days

Countries

India

Contacts

Public ContactDrDattatray Shinde

Bharati Vidyapeeth (Deemed to be University)

dattatray.shinde@bharatividyapeeth.edu9890111954

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026